BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

UP Oncolytics Wins $75,000 Illinois Innovation Voucher To Advance Breakthrough Glioblastoma Therapy

UP Oncolytics, a biotech company in Rosalind Franklin University's Helix 51 biomedical incubator, was awarded an Illinois Innovation Voucher gran...

January 09, 2026 | News

Nuclera Secures First Commercial Sales In Asia With Landmark Installations In Taiwan

Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asi...

January 08, 2026 | News

ProBioGen Signs Master Service Agreement With Zag Bio To Advance Thymus Targeted Antibody Programme

ProBioGen announced the signing of a Master Service Agreement ("MSA") with Zag Bio, Inc., a biotechnology company developing thymus-targete...

January 07, 2026 | News

GenEditBio Secures US FDA IND Clearance For First In Vivo Genome Editing Trial In TGFBI Corneal Dystrophy

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. F...

January 06, 2026 | News

Amphix Bio Secures $12.5 Million Seed Financing To Advance Neurological Therapies

Amphix Bio announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials an...

January 02, 2026 | News

Aptamer Group Licenses Optimer Binder To Alphazyme For Hot Start PCR Applications

-Exclusive OEM license grants worldwide rights for Optimer® binder in molecular biology applications Royalty structure includes product sales, milesto...

December 31, 2025 | News

ABL Bio Lands Strategic 55 Million Funding Boost To Fast Track Next Wave Of Breakthrough Antibody Therapies

Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D on co...

December 29, 2025 | News

NeuroSense Reports Clean Safety Profile From Phase 2 PrimeC Study In Alzheimer’s Disease

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for&nbs...

December 24, 2025 | News

Meiji Seika Pharma Partners With MBC BioLabs To Strengthen Global Biotech Innovation

-Meiji Seika Pharma Co., Ltd. announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting ...

December 22, 2025 | News

Ferronova Raises $6 Million To Advance Nanoparticle Guided Cancer Surgery Technology

Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solut...

December 18, 2025 | News

Eccogene Enrols First Patient In Phase 2a MOSAIC Trial For MASH Therapies

Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammato...

December 18, 2025 | News

GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology di...

December 17, 2025 | News

Thermo Fisher Scientific Advances Microbial Bioprocessing With Chemically Defined Media For Confident Plasmid DNA And Protein Scale Up

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scientific In...

December 16, 2025 | News

Sobi To Acquire Arthrosi Therapeutics In Up To $1.5 Billion Deal

Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which w...

December 16, 2025 | News

Stay Connected